{{knowledge objective
|Identifiant=OIC-236-06-B
|Item_parent=Intracardiac conduction disorders
|Item_parent_short=Intracardiac conduction disorders
|Rank=B
|Title=Knowing tachycardia drugs and emergency treatment
|Description=Use of atropine, isoprenaline and temporary cardiac stimulation
|Rubric=Management
|Contributors=Vincent Galand
|Order=6}}
 

- The urgency of management depends on the tolerance of the bradycardia.

- Resuscitation manoeuvre if patient in cardiorespiratory arrest (sternal punch, if ineffective start external cardiac massage)


If poor tolerance but patient not in cardiorespiratory arrest:

* Tachycardia-inducing drug treatment:

- Isoprenaline (Isuprel): intravenous treatment, protected from light (syringe wrapped in aluminium foil), diluted in G5%. Standard dosage: 5 ampoules of Isoprenaline in 250 cc of G5%. B1 mimetic action (=inotropic and positive chronotropic) and B2 mimetic action (vasodilator and bronchodilator).

Contraindications: digitalis intoxication, ventricular extra systole and tachycardia > 120bpm.

-Atropine: intravenous treatment, 0.5 to 1 mg IVD, renewable every 3 to 5 minutes (max 3 mg). Effective in ischaemic bradycardia, digitalis intoxication, vagal bradycardia.

Contraindications: prolonged QT (risk of torsade de pointe), prostate adenoma, glaucoma.


* Non-drug treatment (in the event of failure of drug treatment or poor tolerance of bradycardia):

- '''Patch d'Ã©lectro stimulation externe''' = External cardiac stimulation

- '''Electro-systolic pacing lead''' = Placement of a temporary lead in the right ventricle by venipuncture.
<br />